Brief: Medicenna Reports Q2 Fiscal 2022 Financial Results And Operational Highlights
12/11/2021 12:34
Nov 12 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $26.7
MILLION AT SEPTEMBER 30, 2021
* FUNDS PROVIDE CO WITH SUFFICIENT CAPITAL TO EXECUTE ITS
CURRENT
PLANNED EXPENDITURES THROUGH END OF CALENDAR 2022
* QTRLY NET LOSS PER SHARE $0.13
* Q2 EARNINGS PER SHARE VIEW C$-0.12 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3m6YCG
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results